Back to top
more

Illumina (ILMN)

(Delayed Data from NSDQ)

$122.87 USD

122.87
1,208,607

-1.59 (-1.28%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $122.87 0.00 (0.00%) 6:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ILMN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Illumina, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,054 2,037 1,339 3,472 3,414
Receivables 734 671 648 487 573
Notes Receivable 0 0 0 0 0
Inventories 587 568 431 372 359
Other Current Assets 234 285 295 152 105
Total Current Assets 2,609 3,561 2,713 4,483 4,451
Net Property & Equipment 1,007 1,091 1,024 922 889
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 20 64
Intangibles 5,538 6,524 10,363 1,039 969
Deposits & Other Assets 413 423 445 589 388
Total Assets 10,111 12,252 15,217 7,585 7,316
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 1,248 0 0 0
Accounts Payable 245 293 332 192 149
Current Portion Long-Term Debt 0 0 0 511 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 1,325 1,232 761 541 516
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 1,570 2,773 1,093 1,244 665
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 702 0 0
Long-Term Debt 1,489 1,487 993 673 1,141
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 620 649 915 303 202
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 4,366 5,653 4,477 2,891 2,703
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 9,555 9,207 8,938 3,815 3,560
Retained Earnings -19 1,142 5,485 4,723 4,067
Other Equity -1 3 17 2 5
Treasury Stock 3,792 3,755 3,702 3,848 3,021
Total Shareholder's Equity 5,745 6,599 10,740 4,694 4,613
Total Liabilities & Shareholder's Equity 10,111 12,252 15,217 7,585 7,316
Total Common Equity 5,745 6,599 10,740 4,694 4,613
Shares Outstanding 158.80 157.30 156.30 146.00 147.00
Book Value Per Share 36.18 41.95 68.71 32.15 31.38

Fiscal Year End for Illumina, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 1,054 933 1,559 1,518
Receivables NA 734 690 741 665
Notes Receivable NA 0 0 0 0
Inventories NA 587 615 617 586
Other Current Assets NA 234 268 306 403
Total Current Assets NA 2,609 2,506 3,223 3,172
Net Property & Equipment NA 1,007 1,040 1,069 1,082
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 5,538 5,556 6,427 6,476
Deposits & Other Assets NA 413 439 417 423
Total Assets NA 10,111 10,122 11,774 11,811
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 750 749
Accounts Payable NA 245 240 244 242
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 1,325 1,242 1,309 1,239
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 1,570 1,482 2,303 2,230
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,489 1,489 1,488 1,487
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 555 702 654
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 4,366 4,224 5,219 5,118
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2 2 2 2
Capital Surplus NA 9,555 9,487 9,397 9,311
Retained Earnings NA -19 157 911 1,145
Other Equity NA -1 21 12 -1
Treasury Stock NA 3,792 3,769 3,767 3,764
Total Shareholder's Equity NA 5,745 5,898 6,555 6,693
Total Liabilities & Shareholder's Equity NA 10,111 10,122 11,774 11,811
Total Common Equity 0 5,745 5,898 6,555 6,693
Shares Outstanding 159.20 158.80 158.30 158.10 158.10
Book Value Per Share 0.00 36.18 37.26 41.46 42.33